{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cannabis sativa", "cannabidiol", "delta-9-tetrahydrocannabinol", "inflammation", "oxidative stress"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35453344", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "29"}], "Language": ["eng"], "ELocationID": ["660", "10.3390/antiox11040660"], "Journal": {"ISSN": "2076-3921", "JournalIssue": {"Volume": "11", "Issue": "4", "PubDate": {"Year": "2022", "Month": "Mar", "Day": "29"}}, "Title": "Antioxidants (Basel, Switzerland)", "ISOAbbreviation": "Antioxidants (Basel)"}, "ArticleTitle": "<i>Cannabis sativa</i> L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation.", "Abstract": {"AbstractText": ["Cannabis (<i>Cannabis sativa</i> L.) plants from the family <i>Cannabidaceae</i> have been used since ancient times, to produce fibers, oil, and for medicinal purposes. Psychoactive delta-9-tetrahydrocannabinol (THC) and nonpsychoactive cannabidiol (CBD) are the main pharmacologically active compounds of <i>Cannabis sativa</i>. These compounds have, for a long time, been under extensive investigation, and their potent antioxidant and inflammatory properties have been reported, although the detailed mechanisms of their actions have not been fully clarified. CB1 receptors are suggested to be responsible for the analgesic effect of THC, while CB2 receptors may account for its immunomodulatory properties. Unlike THC, CBD has a very low affinity for both CB1 and CB2 receptors, and behaves as their negative allosteric modulator. CBD activity, as a CB2 receptor inverse agonist, could be important for CBD anti-inflammatory properties. In this review, we discuss the chemical properties and bioavailability of THC and CBD, their main mechanisms of action, and their role in oxidative stress and inflammation."]}, "AuthorList": [{"Identifier": ["0000-0002-3399-2849"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmaceutical Technologies, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Sukileliu pr. 13, 50161 Kaunas, Lithuania."}], "LastName": "Kopustinskiene", "ForeName": "Dalia M", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, 61200 Brno, Czech Republic."}], "LastName": "Masteikova", "ForeName": "Ruta", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Physiology and Pharmacology, Medical Academy, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania."}], "LastName": "Lazauskas", "ForeName": "Robertas", "Initials": "R"}, {"Identifier": ["0000-0003-1744-2932"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmaceutical Technologies, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Sukileliu pr. 13, 50161 Kaunas, Lithuania."}, {"Identifier": [], "Affiliation": "Department of Drug Technology and Social Pharmacy, Faculty of Pharmacy, Medical Academy, Lithuanian University of Health Sciences, Sukileliu pr. 13, 50161 Kaunas, Lithuania."}], "LastName": "Bernatoniene", "ForeName": "Jurga", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antioxidants (Basel)", "NlmUniqueID": "101668981", "ISSNLinking": "2076-3921"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ben Amar M. Cannabinoids in medicine: A review of their therapeutic potential. J. Ethnopharmacol. 2006;105:1\u201325. doi: 10.1016/j.jep.2006.02.001.", "ArticleIdList": ["10.1016/j.jep.2006.02.001", "16540272"]}, {"Citation": "Addo P.W., Desaulniers Brousseau V., Morello V., MacPherson S., Paris M., Lefsrud M. Cannabis chemistry, post-harvest processing methods and secondary metabolite profiling: A review. Ind. Crop. Prod. 2021;170:113743. doi: 10.1016/j.indcrop.2021.113743.", "ArticleIdList": ["10.1016/j.indcrop.2021.113743"]}, {"Citation": "Salentijn E.M.J., Zhang Q., Amaducci S., Yang M., Trindade L.M. New developments in fiber hemp (Cannabis sativa L.) breeding. Ind. Crop. Prod. 2015;68:32\u201341. doi: 10.1016/j.indcrop.2014.08.011.", "ArticleIdList": ["10.1016/j.indcrop.2014.08.011"]}, {"Citation": "Small E. Evolution and Classification of Cannabis sativa (Marijuana, Hemp) in Relation to Human Utilization. Bot. Rev. 2015;81:189\u2013294. doi: 10.1007/s12229-015-9157-3.", "ArticleIdList": ["10.1007/s12229-015-9157-3"]}, {"Citation": "Crocq M.A. History of cannabis and the endocannabinoid system. Dialogues Clin. Neurosci. 2020;22:223\u2013228.", "ArticleIdList": ["PMC7605027", "33162765"]}, {"Citation": "Charitos I.A., Gagliano-Candela R., Santacroce L., Bottalico L. The Cannabis Spread throughout the Continents and its Therapeutic Use in History. Endocr. Metab. Immune Disord. Drug Targets. 2021;21:407\u2013417. doi: 10.2174/1871530320666200520095900.", "ArticleIdList": ["10.2174/1871530320666200520095900", "32433013"]}, {"Citation": "Robson P. Therapeutic aspects of cannabis and cannabinoids. Br. J. Psychiatry. 2001;178:107\u2013115. doi: 10.1192/bjp.178.2.107.", "ArticleIdList": ["10.1192/bjp.178.2.107", "11157423"]}, {"Citation": "Bonini S.A., Premoli M., Tambaro S., Kumar A., Maccarinelli G., Memo M., Mastinu A. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. J. Ethnopharmacol. 2018;227:300\u2013315. doi: 10.1016/j.jep.2018.09.004.", "ArticleIdList": ["10.1016/j.jep.2018.09.004", "30205181"]}, {"Citation": "Hanu\u0161 L.O., Meyer S.M., Mu\u00f1oz E., Taglialatela-Scafati O., Appendino G. Phytocannabinoids: A unified critical inventory. Nat. Prod. Rep. 2016;33:1357\u20131392. doi: 10.1039/C6NP00074F.", "ArticleIdList": ["10.1039/C6NP00074F", "27722705"]}, {"Citation": "Turner C.E., Elsohly M.A., Boeren E.G. Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J. Nat. Prod. 1980;43:169\u2013234. doi: 10.1021/np50008a001.", "ArticleIdList": ["10.1021/np50008a001", "6991645"]}, {"Citation": "Atakan Z. Cannabis, a complex plant: Different compounds and different effects on individuals. Ther. Adv. Psychopharmacol. 2012;2:241\u2013254. doi: 10.1177/2045125312457586.", "ArticleIdList": ["10.1177/2045125312457586", "PMC3736954", "23983983"]}, {"Citation": "Kogan N.M., Mechoulam R. Cannabinoids in health and disease. Dialogues Clin Neurosci. 2007;9:413\u2013430.", "ArticleIdList": ["PMC3202504", "18286801"]}, {"Citation": "Van den Elsen G.A., Ahmed A.I., Lammers M., Kramers C., Verkes R.J., van der Marck M.A., Rikkert M.G. Efficacy and safety of medical cannabinoids in older subjects: A systematic review. Ageing Res. Rev. 2014;14:56\u201364. doi: 10.1016/j.arr.2014.01.007.", "ArticleIdList": ["10.1016/j.arr.2014.01.007", "24509411"]}, {"Citation": "Kauert G.F., Ramaekers J.G., Schneider E., Moeller M.R., Toennes S.W. Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid. J. Anal. Toxicol. 2007;31:288\u2013293. doi: 10.1093/jat/31.5.288.", "ArticleIdList": ["10.1093/jat/31.5.288", "17579974"]}, {"Citation": "Russo E.B., McPartland J.M. Cannabis is more than simply delta(9)-tetrahydrocannabinol. Psychopharmacology. 2003;165:431\u2013432. doi: 10.1007/s00213-002-1348-z.", "ArticleIdList": ["10.1007/s00213-002-1348-z", "12491031"]}, {"Citation": "McCarberg B.H., Barkin R.L. The future of cannabinoids as analgesic agents: A pharmacologic, pharmacokinetic, and pharmacodynamic overview. Am. J. Ther. 2007;14:475\u2013483. doi: 10.1097/MJT.0b013e3180a5e581.", "ArticleIdList": ["10.1097/MJT.0b013e3180a5e581", "17890938"]}, {"Citation": "Jin D., Henry P., Shan J., Chen J. Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots. Front. Plant Sci. 2021;12 doi: 10.3389/fpls.2021.699530.", "ArticleIdList": ["10.3389/fpls.2021.699530", "PMC8283674", "34276749"]}, {"Citation": "Jin D., Dai K., Xie Z., Chen J. Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes. Sci. Rep. 2020;10:3309. doi: 10.1038/s41598-020-60172-6.", "ArticleIdList": ["10.1038/s41598-020-60172-6", "PMC7039888", "32094454"]}, {"Citation": "Pellati F., Borgonetti V., Brighenti V., Biagi M., Benvenuti S., Corsi L. Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer. Biomed. Res. Int. 2018;2018:1691428. doi: 10.1155/2018/1691428.", "ArticleIdList": ["10.1155/2018/1691428", "PMC6304621", "30627539"]}, {"Citation": "Lucas C.J., Galettis P., Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br. J. Clin. Pharmacol. 2018;84:2477\u20132482. doi: 10.1111/bcp.13710.", "ArticleIdList": ["10.1111/bcp.13710", "PMC6177698", "30001569"]}, {"Citation": "Huestis M.A. Human cannabinoid pharmacokinetics. Chem. Biodivers. 2007;4:1770\u20131804. doi: 10.1002/cbdv.200790152.", "ArticleIdList": ["10.1002/cbdv.200790152", "PMC2689518", "17712819"]}, {"Citation": "Stinchcomb A.L., Valiveti S., Hammell D.C., Ramsey D.R. Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol. J. Pharm. Pharmacol. 2004;56:291\u2013297. doi: 10.1211/0022357022791.", "ArticleIdList": ["10.1211/0022357022791", "15025853"]}, {"Citation": "Mattes R.D., Shaw L.M., Edling-Owens J., Engelman K., Elsohly M.A. Bypassing the first-pass effect for the therapeutic use of cannabinoids. Pharmacol. Biochem. Behav. 1993;44:745\u2013747. doi: 10.1016/0091-3057(93)90194-X.", "ArticleIdList": ["10.1016/0091-3057(93)90194-X", "8383856"]}, {"Citation": "Mattes R.D., Engelman K., Shaw L.M., Elsohly M.A. Cannabinoids and appetite stimulation. Pharmacol. Biochem. Behav. 1994;49:187\u2013195. doi: 10.1016/0091-3057(94)90475-8.", "ArticleIdList": ["10.1016/0091-3057(94)90475-8", "7816872"]}, {"Citation": "Brenneisen R., Egli A., Elsohly M.A., Henn V., Spiess Y. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: A pilot study with 2 patients. Int. J. Clin. Pharmacol. Ther. 1996;34:446\u2013452.", "ArticleIdList": ["8897084"]}, {"Citation": "Linszen D.H., Dingemans P.M., Lenior M.E. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch. Gen. Psychiatry. 1994;51:273\u2013279. doi: 10.1001/archpsyc.1994.03950040017002.", "ArticleIdList": ["10.1001/archpsyc.1994.03950040017002", "8161287"]}, {"Citation": "Hall W. Cannabis use and psychosis. Drug Alcohol. Rev. 1998;17:433\u2013444. doi: 10.1080/09595239800187271.", "ArticleIdList": ["10.1080/09595239800187271", "16203510"]}, {"Citation": "Reilly D., Didcott P., Swift W., Hall W. Long-term cannabis use: Characteristics of users in an Australian rural area. Addiction. 1998;93:837\u2013846. doi: 10.1046/j.1360-0443.1998.9368375.x.", "ArticleIdList": ["10.1046/j.1360-0443.1998.9368375.x", "9744119"]}, {"Citation": "Karila L., Roux P., Rolland B., Benyamina A., Reynaud M., Aubin H.J., Lan\u00e7on C. Acute and long-term effects of cannabis use: A review. Curr. Pharm. Des. 2014;20:4112\u20134118. doi: 10.2174/13816128113199990620.", "ArticleIdList": ["10.2174/13816128113199990620", "24001294"]}, {"Citation": "Mittleman M.A., Lewis R.A., Maclure M., Sherwood J.B., Muller J.E. Triggering myocardial infarction by marijuana. Circulation. 2001;103:2805\u20132809. doi: 10.1161/01.CIR.103.23.2805.", "ArticleIdList": ["10.1161/01.CIR.103.23.2805", "11401936"]}, {"Citation": "Chesney E., Oliver D., Green A., Sovi S., Wilson J., Englund A., Freeman T.P., McGuire P. Adverse effects of cannabidiol: A systematic review and meta-analysis of randomized clinical trials. Neuropsychopharmacology. 2020;45:1799\u20131806. doi: 10.1038/s41386-020-0667-2.", "ArticleIdList": ["10.1038/s41386-020-0667-2", "PMC7608221", "32268347"]}, {"Citation": "Ford T.C., Hayley A.C., Downey L.A., Parrott A.C. Cannabis: An Overview of its Adverse Acute and Chronic Effects and its Implications. Curr. Drug Abus. Rev. 2017;10:6\u201318. doi: 10.2174/1874473710666170712113042.", "ArticleIdList": ["10.2174/1874473710666170712113042", "28707583"]}, {"Citation": "Huestis M.A., Solimini R., Pichini S., Pacifici R., Carlier J., Busard\u00f2 F.P. Cannabidiol Adverse Effects and Toxicity. Curr. Neuropharmacol. 2019;17:974\u2013989. doi: 10.2174/1570159X17666190603171901.", "ArticleIdList": ["10.2174/1570159X17666190603171901", "PMC7052834", "31161980"]}, {"Citation": "Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561\u2013564. doi: 10.1038/346561a0.", "ArticleIdList": ["10.1038/346561a0", "2165569"]}, {"Citation": "Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258:1946\u20131949. doi: 10.1126/science.1470919.", "ArticleIdList": ["10.1126/science.1470919", "1470919"]}, {"Citation": "Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61\u201365. doi: 10.1038/365061a0.", "ArticleIdList": ["10.1038/365061a0", "7689702"]}, {"Citation": "Luo X., Reiter M.A., d\u2019Espaux L., Wong J., Denby C.M., Lechner A., Zhang Y., Grzybowski A.T., Harth S., Lin W., et al. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast. Nature. 2019;567:123\u2013126. doi: 10.1038/s41586-019-0978-9.", "ArticleIdList": ["10.1038/s41586-019-0978-9", "30814733"]}, {"Citation": "Almogi-Hazan O., Or R. Cannabis, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back. Int. J. Mol. Sci. 2020;21:4448. doi: 10.3390/ijms21124448.", "ArticleIdList": ["10.3390/ijms21124448", "PMC7352399", "32585801"]}, {"Citation": "Aizpurua-Olaizola O., Elezgarai I., Rico-Barrio I., Zarandona I., Etxebarria N., Usobiaga A. Targeting the endocannabinoid system: Future therapeutic strategies. Drug Discov. Today. 2017;22:105\u2013110. doi: 10.1016/j.drudis.2016.08.005.", "ArticleIdList": ["10.1016/j.drudis.2016.08.005", "27554802"]}, {"Citation": "Hampson A.J., Grimaldi M., Axelrod J., Wink D. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. USA. 1998;95:8268\u20138273. doi: 10.1073/pnas.95.14.8268.", "ArticleIdList": ["10.1073/pnas.95.14.8268", "PMC20965", "9653176"]}, {"Citation": "Laprairie R.B., Bagher A.M., Kelly M.E., Denovan-Wright E.M. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br. J. Pharmacol. 2015;172:4790\u20134805. doi: 10.1111/bph.13250.", "ArticleIdList": ["10.1111/bph.13250", "PMC4621983", "26218440"]}, {"Citation": "Onaivi E.S., Ishiguro H., Gong J.P., Patel S., Perchuk A., Meozzi P.A., Myers L., Mora Z., Tagliaferro P., Gardner E., et al. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann. N. Y. Acad. Sci. 2006;1074:514\u2013536. doi: 10.1196/annals.1369.052.", "ArticleIdList": ["10.1196/annals.1369.052", "17105950"]}, {"Citation": "Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 2005;310:329\u2013332. doi: 10.1126/science.1115740.", "ArticleIdList": ["10.1126/science.1115740", "16224028"]}, {"Citation": "Apostu D., Lucaciu O., Mester A., Benea H., Oltean-Dan D., Onisor F., Baciut M., Bran S. Cannabinoids and bone regeneration. Drug Metab. Rev. 2019;51:65\u201375. doi: 10.1080/03602532.2019.1574303.", "ArticleIdList": ["10.1080/03602532.2019.1574303", "30702341"]}, {"Citation": "Piscitelli F., Silvestri C. Role of the Endocannabinoidome in Human and Mouse Atherosclerosis. Curr. Pharm. Des. 2019;25:3147\u20133164. doi: 10.2174/1381612825666190826162735.", "ArticleIdList": ["10.2174/1381612825666190826162735", "31448709"]}, {"Citation": "Shahbazi F., Grandi V., Banerjee A., Trant J.F. Cannabinoids and Cannabinoid Receptors: The Story so Far. IScience. 2020;23:101301. doi: 10.1016/j.isci.2020.101301.", "ArticleIdList": ["10.1016/j.isci.2020.101301", "PMC7339067", "32629422"]}, {"Citation": "Pertwee R.G. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br. J. Pharmacol. 2008;153:199\u2013215. doi: 10.1038/sj.bjp.0707442.", "ArticleIdList": ["10.1038/sj.bjp.0707442", "PMC2219532", "17828291"]}, {"Citation": "Maccarrone M., Bab I., B\u00edr\u00f3 T., Cabral G.A., Dey S.K., Di Marzo V., Konje J.C., Kunos G., Mechoulam R., Pacher P., et al. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol. Sci. 2015;36:277\u2013296. doi: 10.1016/j.tips.2015.02.008.", "ArticleIdList": ["10.1016/j.tips.2015.02.008", "PMC4420685", "25796370"]}, {"Citation": "Karst M., Salim K., Burstein S., Conrad I., Hoy L., Schneider U. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: A randomized controlled trial. JAMA. 2003;290:1757\u20131762. doi: 10.1001/jama.290.13.1757.", "ArticleIdList": ["10.1001/jama.290.13.1757", "14519710"]}, {"Citation": "Rock E.M., Bolognini D., Limebeer C.L., Cascio M.G., Anavi-Goffer S., Fletcher P.J., Mechoulam R., Pertwee R.G., Parker L.A. Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus. Br. J. Pharmacol. 2012;165:2620\u20132634. doi: 10.1111/j.1476-5381.2011.01621.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01621.x", "PMC3423241", "21827451"]}, {"Citation": "Baker D., Pryce G., Croxford J.L., Brown P., Pertwee R.G., Huffman J.W., Layward L. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature. 2000;404:84\u201387. doi: 10.1038/35003583.", "ArticleIdList": ["10.1038/35003583", "10716447"]}, {"Citation": "Malfait A.M., Gallily R., Sumariwalla P.F., Malik A.S., Andreakos E., Mechoulam R., Feldmann M. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA. 2000;97:9561\u20139566. doi: 10.1073/pnas.160105897.", "ArticleIdList": ["10.1073/pnas.160105897", "PMC16904", "10920191"]}, {"Citation": "McPartland J.M., Glass M., Pertwee R.G. Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: Interspecies differences. Br. J. Pharmacol. 2007;152:583\u2013593. doi: 10.1038/sj.bjp.0707399.", "ArticleIdList": ["10.1038/sj.bjp.0707399", "PMC2190026", "17641667"]}, {"Citation": "Tham M., Yilmaz O., Alaverdashvili M., Kelly M.E.M., Denovan-Wright E.M., Laprairie R.B. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Br. J. Pharmacol. 2019;176:1455\u20131469. doi: 10.1111/bph.14440.", "ArticleIdList": ["10.1111/bph.14440", "PMC6487556", "29981240"]}, {"Citation": "Ol\u00e1h A., Szekanecz Z., B\u00edr\u00f3 T. Targeting Cannabinoid Signaling in the Immune System: \u201cHigh\u201d-ly Exciting Questions, Possibilities, and Challenges. Front. Immunol. 2017;8:1487. doi: 10.3389/fimmu.2017.01487.", "ArticleIdList": ["10.3389/fimmu.2017.01487", "PMC5686045", "29176975"]}, {"Citation": "Burstein S. Cannabidiol (CBD) and its analogs: A review of their effects on inflammation. Bioorganic Med. Chem. 2015;23:1377\u20131385. doi: 10.1016/j.bmc.2015.01.059.", "ArticleIdList": ["10.1016/j.bmc.2015.01.059", "25703248"]}, {"Citation": "Elmes M.W., Kaczocha M., Berger W.T., Leung K., Ralph B.P., Wang L., Sweeney J.M., Miyauchi J.T., Tsirka S.E., Ojima I., et al. Fatty acid-binding proteins (FABPs) are intracellular carriers for \u03949-tetrahydrocannabinol (THC) and cannabidiol (CBD) J. Biol. Chem. 2015;290:8711\u20138721. doi: 10.1074/jbc.M114.618447.", "ArticleIdList": ["10.1074/jbc.M114.618447", "PMC4423662", "25666611"]}, {"Citation": "Dawidowicz A.L., Olszowy-Tomczyk M., Typek R. CBG, CBD, \u03949-THC, CBN, CBGA, CBDA and \u03949-THCA as antioxidant agents and their intervention abilities in antioxidant action. Fitoterapia. 2021;152:104915. doi: 10.1016/j.fitote.2021.104915.", "ArticleIdList": ["10.1016/j.fitote.2021.104915", "33964342"]}, {"Citation": "Hacke A.C.M., Lima D., de Costa F., Deshmukh K., Li N., Chow A.M., Marques J.A., Pereira R.P., Kerman K. Probing the antioxidant activity of \u0394(9)-tetrahydrocannabinol and cannabidiol in Cannabis sativa extracts. Analyst. 2019;144:4952\u20134961. doi: 10.1039/C9AN00890J.", "ArticleIdList": ["10.1039/C9AN00890J", "31318364"]}, {"Citation": "Caprioglio D., Mattoteia D., Pollastro F., Negri R., Lopatriello A., Chianese G., Minassi A., Collado J.A., Munoz E., Taglialatela-Scafati O., et al. The Oxidation of Phytocannabinoids to Cannabinoquinoids. J. Nat. Prod. 2020;83:1711\u20131715. doi: 10.1021/acs.jnatprod.9b01284.", "ArticleIdList": ["10.1021/acs.jnatprod.9b01284", "PMC7997633", "32315173"]}, {"Citation": "Hampson A.J., Grimaldi M., Lolic M., Wink D., Rosenthal R., Axelrod J. Neuroprotective antioxidants from marijuana. Ann. N. Y. Acad. Sci. 2000;899:274\u2013282. doi: 10.1111/j.1749-6632.2000.tb06193.x.", "ArticleIdList": ["10.1111/j.1749-6632.2000.tb06193.x", "10863546"]}, {"Citation": "Chen Y., Buck J. Cannabinoids protect cells from oxidative cell death: A receptor-independent mechanism. J. Pharmacol. Exp. Ther. 2000;293:807\u2013812.", "ArticleIdList": ["10869379"]}, {"Citation": "Hamelink C., Hampson A., Wink D.A., Eiden L.E., Eskay R.L. Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity. J. Pharmacol. Exp. Ther. 2005;314:780\u2013788. doi: 10.1124/jpet.105.085779.", "ArticleIdList": ["10.1124/jpet.105.085779", "PMC4183207", "15878999"]}, {"Citation": "Lastres-Becker I., Molina-Holgado F., Ramos J.A., Mechoulam R., Fern\u00e1ndez-Ruiz J. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson\u2019s disease. Neurobiol. Dis. 2005;19:96\u2013107. doi: 10.1016/j.nbd.2004.11.009.", "ArticleIdList": ["10.1016/j.nbd.2004.11.009", "15837565"]}, {"Citation": "Garc\u00eda-Arencibia M., Gonz\u00e1lez S., de Lago E., Ramos J.A., Mechoulam R., Fern\u00e1ndez-Ruiz J. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson\u2019s disease: Importance of antioxidant and cannabinoid receptor-independent properties. Brain Res. 2007;1134:162\u2013170. doi: 10.1016/j.brainres.2006.11.063.", "ArticleIdList": ["10.1016/j.brainres.2006.11.063", "17196181"]}, {"Citation": "Comelli F., Bettoni I., Colleoni M., Giagnoni G., Costa B. Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress. Phytother. Res. 2009;23:1678\u20131684. doi: 10.1002/ptr.2806.", "ArticleIdList": ["10.1002/ptr.2806", "19441010"]}, {"Citation": "Marsicano G., Moosmann B., Hermann H., Lutz B., Behl C. Neuroprotective properties of cannabinoids against oxidative stress: Role of the cannabinoid receptor CB1. J. Neurochem. 2002;80:448\u2013456. doi: 10.1046/j.0022-3042.2001.00716.x.", "ArticleIdList": ["10.1046/j.0022-3042.2001.00716.x", "11905991"]}, {"Citation": "Baeeri M., Rahimifard M., Daghighi S.M., Khan F., Salami S.A., Moini-Nodeh S., Haghi-Aminjan H., Bayrami Z., Rezaee F., Abdollahi M. Cannabinoids as anti-ROS in aged pancreatic islet cells. Life Sci. 2020;256:117969. doi: 10.1016/j.lfs.2020.117969.", "ArticleIdList": ["10.1016/j.lfs.2020.117969", "32553926"]}, {"Citation": "Chen J., Errico S.L., Freed W.J. Reactive oxygen species and p38 phosphorylation regulate the protective effect of Delta9-tetrahydrocannabinol in the apoptotic response to NMDA. Neurosci. Lett. 2005;389:99\u2013103. doi: 10.1016/j.neulet.2005.07.028.", "ArticleIdList": ["10.1016/j.neulet.2005.07.028", "PMC1790967", "16098661"]}, {"Citation": "Atalay S., Jarocka-Karpowicz I., Skrzydlewska E. Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants. 2019;9:21. doi: 10.3390/antiox9010021.", "ArticleIdList": ["10.3390/antiox9010021", "PMC7023045", "31881765"]}, {"Citation": "Nagarkatti P., Pandey R., Rieder S.A., Hegde V.L., Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med. Chem. 2009;1:1333\u20131349. doi: 10.4155/fmc.09.93.", "ArticleIdList": ["10.4155/fmc.09.93", "PMC2828614", "20191092"]}, {"Citation": "Lima M.G., Tardelli V.S., Brietzke E., Fidalgo T.M. Cannabis and Inflammatory Mediators. Eur. Addict. Res. 2021;27:16\u201324. doi: 10.1159/000508840.", "ArticleIdList": ["10.1159/000508840", "32726782"]}, {"Citation": "Lipina C., Hundal H.S. Modulation of cellular redox homeostasis by the endocannabinoid system. Open Biol. 2016;6:150276. doi: 10.1098/rsob.150276.", "ArticleIdList": ["10.1098/rsob.150276", "PMC4852457", "27248801"]}, {"Citation": "Rajesh M., Mukhopadhyay P., B\u00e1tkai S., Patel V., Saito K., Matsumoto S., Kashiwaya Y., Horv\u00e1th B., Mukhopadhyay B., Becker L., et al. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J. Am. Coll. Cardiol. 2010;56:2115\u20132125. doi: 10.1016/j.jacc.2010.07.033.", "ArticleIdList": ["10.1016/j.jacc.2010.07.033", "PMC3026637", "21144973"]}, {"Citation": "Costa B., Trovato A.E., Comelli F., Giagnoni G., Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur. J. Pharmacol. 2007;556:75\u201383. doi: 10.1016/j.ejphar.2006.11.006.", "ArticleIdList": ["10.1016/j.ejphar.2006.11.006", "17157290"]}, {"Citation": "Biernacki M., Jastrz\u0105b A., Skrzydlewska E. Changes in Hepatic Phospholipid Metabolism in Rats under UV Irradiation and Topically Treated with Cannabidiol. Antioxidants. 2021;10:1157. doi: 10.3390/antiox10081157.", "ArticleIdList": ["10.3390/antiox10081157", "PMC8388943", "34439405"]}, {"Citation": "Khaksar S., Bigdeli M., Samiee A., Shirazi-Zand Z. Antioxidant and anti-apoptotic effects of cannabidiol in model of ischemic stroke in rats. Brain Res. Bull. 2022;180:118\u2013130. doi: 10.1016/j.brainresbull.2022.01.001.", "ArticleIdList": ["10.1016/j.brainresbull.2022.01.001", "35031355"]}, {"Citation": "Katchan V., David P., Shoenfeld Y. Cannabinoids and autoimmune diseases: A systematic review. Autoimmun. Rev. 2016;15:513\u2013528. doi: 10.1016/j.autrev.2016.02.008.", "ArticleIdList": ["10.1016/j.autrev.2016.02.008", "26876387"]}, {"Citation": "Klein T.W., Cabral G.A. Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. J. Neuroimmune Pharmacol. 2006;1:50\u201364. doi: 10.1007/s11481-005-9007-x.", "ArticleIdList": ["10.1007/s11481-005-9007-x", "18040791"]}, {"Citation": "Suryavanshi S.V., Kovalchuk I., Kovalchuk O. Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective. Front. Immunol. 2020;11:613613. doi: 10.3389/fimmu.2020.613613.", "ArticleIdList": ["10.3389/fimmu.2020.613613", "PMC7876066", "33584697"]}, {"Citation": "Nichols J.M., Kaplan B.L.F. Immune Responses Regulated by Cannabidiol. Cannabis Cannabinoid Res. 2020;5:12\u201331. doi: 10.1089/can.2018.0073.", "ArticleIdList": ["10.1089/can.2018.0073", "PMC7173676", "32322673"]}, {"Citation": "Derocq J.M., Jbilo O., Bouaboula M., S\u00e9gui M., Cl\u00e8re C., Casellas P. Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation. J. Biol. Chem. 2000;275:15621\u201315628. doi: 10.1074/jbc.275.21.15621.", "ArticleIdList": ["10.1074/jbc.275.21.15621", "10821843"]}, {"Citation": "Puffenbarger R.A., Boothe A.C., Cabral G.A. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia. 2000;29:58\u201369. doi: 10.1002/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.0.CO;2-W.", "ArticleIdList": ["10.1002/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.0.CO;2-W", "10594923"]}, {"Citation": "Salazar M., Carracedo A., Salanueva I.J., Hern\u00e1ndez-Tiedra S., Lorente M., Egia A., V\u00e1zquez P., Bl\u00e1zquez C., Torres S., Garc\u00eda S., et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Investig. 2009;119:1359\u20131372. doi: 10.1172/JCI37948.", "ArticleIdList": ["10.1172/JCI37948", "PMC2673842", "19425170"]}, {"Citation": "Guzm\u00e1n M., Duarte M.J., Bl\u00e1zquez C., Ravina J., Rosa M.C., Galve-Roperh I., S\u00e1nchez C., Velasco G., Gonz\u00e1lez-Feria L. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br. J. Cancer. 2006;95:197\u2013203. doi: 10.1038/sj.bjc.6603236.", "ArticleIdList": ["10.1038/sj.bjc.6603236", "PMC2360617", "16804518"]}, {"Citation": "Helcman M., \u0160mejkal K. Biological activity of Cannabis compounds: A modern approach to the therapy of multiple diseases. Phytochem. Rev. 2021 doi: 10.1007/s11101-021-09777-x.", "ArticleIdList": ["10.1007/s11101-021-09777-x"]}, {"Citation": "Bl\u00e1zquez C., Gonz\u00e1lez-Feria L., Alvarez L., Haro A., Casanova M.L., Guzm\u00e1n M. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res. 2004;64:5617\u20135623. doi: 10.1158/0008-5472.CAN-03-3927.", "ArticleIdList": ["10.1158/0008-5472.CAN-03-3927", "15313899"]}, {"Citation": "Scuderi C., Steardo L., Esposito G. Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement. Phytother. Res. 2014;28:1007\u20131013. doi: 10.1002/ptr.5095.", "ArticleIdList": ["10.1002/ptr.5095", "24288245"]}, {"Citation": "Gyires K., Z\u00e1dori Z.S. Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation. Curr. Neuropharmacol. 2016;14:935\u2013951. doi: 10.2174/1570159X14666160303110150.", "ArticleIdList": ["10.2174/1570159X14666160303110150", "PMC5333598", "26935536"]}, {"Citation": "Lahat A., Lang A., Ben-Horin S. Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: A pilot prospective study. Digestion. 2012;85:1\u20138. doi: 10.1159/000332079.", "ArticleIdList": ["10.1159/000332079", "22095142"]}, {"Citation": "Lal S., Prasad N., Ryan M., Tangri S., Silverberg M.S., Gordon A., Steinhart H. Cannabis use amongst patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 2011;23:891\u2013896. doi: 10.1097/MEG.0b013e328349bb4c.", "ArticleIdList": ["10.1097/MEG.0b013e328349bb4c", "21795981"]}, {"Citation": "Naftali T., Lev L.B., Yablecovitch D., Half E., Konikoff F.M. Treatment of Crohn\u2019s disease with cannabis: An observational study. Isr. Med. Assoc. J. 2011;13:455\u2013458.", "ArticleIdList": ["21910367"]}, {"Citation": "Storr M., Devlin S., Kaplan G.G., Panaccione R., Andrews C.N. Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn\u2019s disease. Inflamm. Bowel Dis. 2014;20:472\u2013480. doi: 10.1097/01.MIB.0000440982.79036.d6.", "ArticleIdList": ["10.1097/01.MIB.0000440982.79036.d6", "24407485"]}, {"Citation": "Schicho R., Storr M. Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice. Pharmacology. 2012;89:149\u2013155. doi: 10.1159/000336871.", "ArticleIdList": ["10.1159/000336871", "PMC3668621", "22414698"]}, {"Citation": "Irving P.M., Iqbal T., Nwokolo C., Subramanian S., Bloom S., Prasad N., Hart A., Murray C., Lindsay J.O., Taylor A., et al. A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis. Inflamm. Bowel Dis. 2018;24:714\u2013724. doi: 10.1093/ibd/izy002.", "ArticleIdList": ["10.1093/ibd/izy002", "29538683"]}, {"Citation": "Mestre L., Carrillo-Salinas F.J., Mecha M., Feli\u00fa A., Guaza C. Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis. Biochem. Pharmacol. 2018;157:51\u201366. doi: 10.1016/j.bcp.2018.08.037.", "ArticleIdList": ["10.1016/j.bcp.2018.08.037", "30171835"]}, {"Citation": "Cluny N.L., Reimer R.A., Sharkey K.A. Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis. Brain Behav. Immun. 2012;26:691\u2013698. doi: 10.1016/j.bbi.2012.01.004.", "ArticleIdList": ["10.1016/j.bbi.2012.01.004", "22269477"]}, {"Citation": "Al-Ghezi Z.Z., Busbee P.B., Alghetaa H., Nagarkatti P.S., Nagarkatti M. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. Brain Behav. Immun. 2019;82:25\u201335. doi: 10.1016/j.bbi.2019.07.028.", "ArticleIdList": ["10.1016/j.bbi.2019.07.028", "PMC6866665", "31356922"]}, {"Citation": "O\u2019Sullivan S.E., Yates A.S., Porter R.K. The Peripheral Cannabinoid Receptor Type 1 (CB(1)) as a Molecular Target for Modulating Body Weight in Man. Molecules. 2021;26:6178. doi: 10.3390/molecules26206178.", "ArticleIdList": ["10.3390/molecules26206178", "PMC8538448", "34684760"]}, {"Citation": "Bisogno T., Lauritano A., Piscitelli F. The Endocannabinoid System: A Bridge between Alzheimer\u2019s Disease and Gut Microbiota. Life. 2021;11:934. doi: 10.3390/life11090934.", "ArticleIdList": ["10.3390/life11090934", "PMC8470731", "34575083"]}, {"Citation": "Iannotti F.A., Di Marzo V. The gut microbiome, endocannabinoids and metabolic disorders. J. Endocrinol. 2021;248:R83\u2013R97. doi: 10.1530/JOE-20-0444.", "ArticleIdList": ["10.1530/JOE-20-0444", "33337346"]}, {"Citation": "Kienzl M., Storr M., Schicho R. Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. Clin. Transl. Gastroenterol. 2020;11:e00120. doi: 10.14309/ctg.0000000000000120.", "ArticleIdList": ["10.14309/ctg.0000000000000120", "PMC7056045", "31899693"]}, {"Citation": "Di Marzo V., Silvestri C. Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome. Nutrients. 2019;11:1956. doi: 10.3390/nu11081956.", "ArticleIdList": ["10.3390/nu11081956", "PMC6722643", "31434293"]}, {"Citation": "Rea K., SM O.M., Cryan J.F. High and Mighty? Cannabinoids and the microbiome in pain. Neurobiol. Pain. 2021;9:100061. doi: 10.1016/j.ynpai.2021.100061.", "ArticleIdList": ["10.1016/j.ynpai.2021.100061", "PMC7905370", "33665479"]}, {"Citation": "Cox A.J., West N.P., Cripps A.W. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015;3:207\u2013215. doi: 10.1016/S2213-8587(14)70134-2.", "ArticleIdList": ["10.1016/S2213-8587(14)70134-2", "25066177"]}, {"Citation": "Saad M.J., Santos A., Prada P.O. Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance. Physiology. 2016;31:283\u2013293. doi: 10.1152/physiol.00041.2015.", "ArticleIdList": ["10.1152/physiol.00041.2015", "27252163"]}, {"Citation": "Scheithauer T.P.M., Rampanelli E., Nieuwdorp M., Vallance B.A., Verchere C.B., van Raalte D.H., Herrema H. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes. Front. Immunol. 2020;11:571731. doi: 10.3389/fimmu.2020.571731.", "ArticleIdList": ["10.3389/fimmu.2020.571731", "PMC7596417", "33178196"]}, {"Citation": "Torres-Fuentes C., Schellekens H., Dinan T.G., Cryan J.F. The microbiota-gut-brain axis in obesity. Lancet Gastroenterol. Hepatol. 2017;2:747\u2013756. doi: 10.1016/S2468-1253(17)30147-4.", "ArticleIdList": ["10.1016/S2468-1253(17)30147-4", "28844808"]}, {"Citation": "Adamczyk-Sowa M., Medrek A., Madej P., Michlicka W., Dobrakowski P. Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology? J. Immunol. Res. 2017;2017:7904821. doi: 10.1155/2017/7904821.", "ArticleIdList": ["10.1155/2017/7904821", "PMC5337874", "28316999"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "28"}, {"Year": "2022", "Month": "3", "Day": "24"}, {"Year": "2022", "Month": "3", "Day": "28"}, {"Year": "2022", "Month": "4", "Day": "23", "Hour": "1", "Minute": "1"}, {"Year": "2022", "Month": "4", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "3", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["35453344", "PMC9030479", "10.3390/antiox11040660", "antiox11040660"]}}], "PubmedBookArticle": []}